Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews


Print Page Follow BioNews on Twitter BioNews RSS feed

Like the Progress Educational Trust on Facebook



King's College London - Health: More than a medical matter





The root of the problem: clues about male pattern baldness

26 March 2012

By Dr Zara Mahmoud

Appeared in BioNews 650

New treatments for male pattern baldness could be on the way, as scientists identify a protein they believe inhibits growth of hair follicles.

Male pattern baldness, or androgenetic alopecia (AGA), affects 80 percent of men at some point in their lives, but very little is known about the molecular mechanisms of the condition.

The team at the University of Pennsylvania analysed which genes were expressed in samples of balding and non-balding scalp tissue from five men with AGA. They found elevated levels of the enzyme prostaglandin D2 synthase, and its product prostaglandin D2 (PGD2) in samples from bald areas, almost three times above normal levels.

Dr George Cotsarelis, the lead author of the study, explained that previous work showed the scalps of bald men retained hair follicle stem cells, but these cells were incapable of developing into mature hair follicles.

'At that time, we hypothesised there is either a lack of an activator in the scalp or the presence of an inhibitor that prevented the stem cells from generating hair', he added.

The latest research, published in Science Translational Medicine, found that healthy hair follicles treated with increasing amounts of PGD2 in the lab started to shrink, and eventually the hairs stopped growing. A similar hair loss pattern was observed in mice bred to have high levels of the protein.

Dr Cotsarelis said: 'We think if we are able to remove the inhibitory effects of PGD2 we would be able to allow the hair to grow'.

Prostaglandins are chemical messengers that regulate a variety of physiological responses in the body, such as the inflammatory response observed during infection. They work by binding to cell surface receptors on their target cells, including the GPR44 receptor on hair follicles. Blocking these receptors should inhibit the effects of this protein.

The good news is that there are already several experimental drugs in clinical trials that block the GPR44 receptor. Some of these drugs are being tested as a possible treatment for asthma, as prostaglandins have been implicated in the contraction of the airways during an asthma attack. However, when applied topically they might be able to reverse the inhibitory effects of prostaglandins on hair follicles.

'The next question is whether it can prevent further hair loss, or actually reverse hair loss and re-grow hair on a bald scalp', said Dr Cotsarelis.

 

SOURCES & REFERENCES
BBC | 21 March 2012
 
Nature News | 21 March 2012
 
Prostaglandin D2 Inhibits Hair Growth and Is Elevated in Bald Scalp of Men with Androgenetic Alopecia
Science Translational Medicine | 21 March 2012
 
Time | 22 March 2012
 
Globe and Mail | 22 March 2012
 

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

28 October 2013 - by Dr Naqash Raja 
Regions of the genome that do not code for proteins have been found to shape facial features, research at the Lawrence Berkeley National Laboratory, USA, has shown... [Read More]
23 April 2012 - by Greg Ball 
Functioning hair follicles have been grown in hairless mice by researchers in Japan, offering hope of a future treatment for baldness and alopecia in humans. The study is the first to report creating viable hair follicles using human cells, according to Nature News.... [Read More]

05 September 2011 - by Kimberley Bryon-Dodd 
Fat cells may hold the key to triggering hair growth, US researchers have found. They discovered that a layer of fat cells under the skin of mice sends chemical messages to stem cells, instructing them to grow hair... [Read More]
10 January 2011 - by Dr Rachael Panizzo 
Faulty stem cells may cause the onset of male pattern baldness, scientists have found. Professor George Cotsarelis and colleagues at the University of Pennsylvania School of Medicine in Philadelphia discovered that stem cells are present in the hair follicles of both bald and hairy scalp regions in men with male pattern baldness... [Read More]
19 April 2010 - by Dr Lux Fatimathas 
A genetic mutation associated with childhood hereditary baldness has been identified by an US-led study. Researchers discovered a mutation in the APCDD1 gene was common to three families of Italian or Pakistani origin, who were affected by hereditary hypotrichosis simplex (HSS). This disease results in the shrinking of hair follicles and thinning of the hair... [Read More]
20 October 2008 - by Adam Fletcher 
Two independent studies have uncovered a genetic variation that increases a man's chances of developing baldness. Professor Tim Spector at Kings College London, UK, and Professor Axel Hillmer at the University of Bonn, Germany, are the first to use a gene-hunting technique in order to identify traits... [Read More]

HAVE YOUR SAY
Be the first to have your say.

You need to Login or Register to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions

 


 

- click here to enquire about using this story.

Printer Friendly Page

Published by the Progress Educational Trust
RISK ASSESSMENT:
BREAST CANCER, PREDICTION AND SCREENING
FREE public event in central London, 6.30pm on Thursday 8 May 2014 - find out more HERE

DataLabel Supplying Printed Labels To The UK For Over 15 Years

ANNIVERSARY APPEAL
Please donate HERE, so that the Progress Educational Trust can continue throughout 2014 (and beyond) while keeping BioNews FREE for you to read

The Progress Educational Trust was shortlisted for the Charity Times Awards 2011

Advertise your products and services HERE - click for further details

Good Fundraising Code

Become a Friend of PET HERE, and give the Progress Educational Trust a regular donation